Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1986-01-24
1988-09-13
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514177, 514178, 514179, 514180, 514181, 514172, A61K 3156, A61K 3158
Patent
active
047710420
ABSTRACT:
A method of inhibiting angiogenesis in a warm blooded animal which comprises administering to said animal an anti-angiogenic effective amount of a compound of the formula: ##STR1## wherein the dotted line between positions C-1 and C-2 means the presence or absence of a double bond; the .about.bond at C-6 denotes .alpha. or .beta.;
REFERENCES:
Folkman, Jr., Proceedings of AACR 26 (Mar. 1985), 384-385.
Folkman, J., et al., Science 221 (Aug. 19, 1983), 719-725.
Braughler John M.
Folkman Judah
Hall Edward D.
McCall John M.
Wierenga Wendell
Lipovsky Joseph A.
Newtson Ruth Hattan
Schenkman Leonard
The Upjohn Company
LandOfFree
Inhibition of angiogenesis involving the coadministration of ste does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of angiogenesis involving the coadministration of ste, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of angiogenesis involving the coadministration of ste will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-807083